{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T07:31:37Z","timestamp":1775979097437,"version":"3.50.1"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T00:00:00Z","timestamp":1367280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0062833","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T17:14:14Z","timestamp":1367428454000},"page":"e62833","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":82,"title":["Rosiglitazone Treatment of Type 2 Diabetic db\/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion"],"prefix":"10.1371","volume":"8","author":[{"given":"Harshita","family":"Chodavarapu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadja","family":"Grobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hari K.","family":"Somineni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esam S. B.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malav","family":"Madhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid M.","family":"Elased","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,4,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/bmj.314.7083.783","article-title":"Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study","volume":"314","author":"MA Gall","year":"1997","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/pr.59.3.3","article-title":"The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease","volume":"59","author":"H Kobori","year":"2007","journal-title":"Pharmacol Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1113\/expphysiol.2008.046474","article-title":"Cardiovascular and autonomic phenotype of db\/db diabetic mice","volume":"94","author":"D Senador","year":"2009","journal-title":"Exp Physiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2147\/VHRM.S1905","article-title":"The renin-angiotensin system and diabetes: an update","volume":"4","author":"A Ribeiro-Oliveira Jr","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"ref5","first-page":"151","article-title":"Dual blockade of the renin-angiotensin-aldosterone system is safe and effective in reducing albuminuria in Asian type 2 diabetic patients with nephropathy","volume":"51","author":"F Tan","year":"2010","journal-title":"Singapore Med J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"SR Tipnis","year":"2000","journal-title":"J Biol Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"C Vickers","year":"2002","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2337\/db06-0033","article-title":"ACE and ACE2 activity in diabetic mice","volume":"55","author":"J Wysocki","year":"2006","journal-title":"Diabetes"},{"key":"ref9","first-page":"E91","article-title":"Balance of ACE and ACE2 in diabetes: Decreased renal ACE2 activity in hypertensive db\/db diabetic mice","volume":"52","author":"MB Monteiro","year":"2008","journal-title":"Hypertension"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/1074248412460124","article-title":"Enhanced Angiotensin II-Induced Cardiac and Aortic Remodeling in ACE2 Knockout Mice","volume":"18","author":"MS Alghamri","year":"2012","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1681\/ASN.2006050423","article-title":"Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes","volume":"17","author":"M Ye","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/sj.ki.5002373","article-title":"ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice","volume":"72","author":"MJ Soler","year":"2007","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/mt.2011.155","article-title":"ACE2 and Ang-(1\u20137) Confer Protection Against Development of Diabetic Retinopathy","volume":"20","author":"A Verma","year":"2012","journal-title":"Molecular Therapy"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/molmed.2010.00111","article-title":"Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition","volume":"17","author":"CX Liu","year":"2011","journal-title":"Mol Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ki.2012.83","article-title":"Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice","volume":"82","author":"R Nadarajah","year":"2012","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s00125-008-0988-x","article-title":"Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy","volume":"51","author":"G Wang","year":"2008","journal-title":"Diabetologia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1440-1797.2011.01467.x","article-title":"Urinary angiotensin-converting enzyme 2 in patients with CKD","volume":"16","author":"S Mizuiri","year":"2011","journal-title":"Nephrology (Carlton )"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e37649","DOI":"10.1371\/journal.pone.0037649","article-title":"Increased urinary Angiotensin-converting enzyme 2 in renal transplant patients with diabetes","volume":"7","author":"F Xiao","year":"2012","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"37459","DOI":"10.1074\/jbc.M305877200","article-title":"Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17)","volume":"278","author":"KJ Garton","year":"2003","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"50510","DOI":"10.1074\/jbc.M208738200","article-title":"Metalloprotease-mediated GH receptor proteolysis and GHBP shedding. Determination of extracellular domain stem region cleavage site","volume":"277","author":"X Wang","year":"2002","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.282.5392.1281","article-title":"An essential role for ectodomain shedding in mammalian development","volume":"282","author":"JJ Peschon","year":"1998","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"30113","DOI":"10.1074\/jbc.M505111200","article-title":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)","volume":"280","author":"DW Lambert","year":"2005","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"L84","DOI":"10.1152\/ajplung.00071.2009","article-title":"Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia","volume":"297","author":"HP Jia","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"F1341","DOI":"10.1152\/ajprenal.00349.2012","article-title":"Loss of TIMP3 selectively exacerbates diabetic nephropathy","volume":"303","author":"R Basu","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/HYPERTENSIONAHA.107.097519","article-title":"Is peroxisome proliferator-activated receptor-gamma a new \u201cpal\u201d of renin?","volume":"50","author":"ET Weatherford","year":"2007","journal-title":"Hypertension"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"SE Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.2337\/diabetes.54.7.2206","article-title":"Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients","volume":"54","author":"F Pistrosch","year":"2005","journal-title":"Diabetes"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.amjhyper.2004.09.010","article-title":"The effect of rosiglitazone on urine albumin excretion in patients with type 2 diabetes mellitus and hypertension","volume":"18","author":"PA Sarafidis","year":"2005","journal-title":"Am J Hypertens"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-2008-1042429","article-title":"Chronic rosiglitazone therapy normalizes expression of ACE1, SCD1 and other genes in the kidney of obese Zucker rats as determined by microarray analysis","volume":"116","author":"J Song","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2840-10-10","article-title":"Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro","volume":"10","author":"L Ren","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.0000161954.17870.5D","article-title":"Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone","volume":"111","author":"A Harte","year":"2005","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nm1275","article-title":"Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach","volume":"11","author":"A Lautrette","year":"2005","journal-title":"Nat Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81294-5","article-title":"Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db\/db mice","volume":"84","author":"H Chen","year":"1996","journal-title":"Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/01.HYP.0000215588.38536.30","article-title":"New mass spectrometric assay for angiotensin-converting enzyme 2 activity","volume":"47","author":"KM Elased","year":"2006","journal-title":"Hypertension"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1016\/j.amjhyper.2004.08.004","article-title":"The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications","volume":"17","author":"ME Cooper","year":"2004","journal-title":"Am J Hypertens"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nrd2685","article-title":"Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection","volume":"7","author":"N Perico","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2353\/ajpath.2006.051091","article-title":"Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis","volume":"168","author":"GY Oudit","year":"2006","journal-title":"Am J Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"13185","DOI":"10.1021\/bi035268s","article-title":"Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence","volume":"42","author":"JL Guy","year":"2003","journal-title":"Biochemistry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-12-0341","article-title":"Angiotensin-converting enzyme 2, Angiotensin-(1\u20137) and Mas: new players of the Renin Angiotensin System","volume":"216","author":"RA Santos","year":"2013","journal-title":"J Endocrinol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1111\/j.1432-1033.2004.04184.x","article-title":"The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein","volume":"271","author":"TM Allinson","year":"2004","journal-title":"Eur J Biochem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/BF00400475","article-title":"The link between hyperglycaemia and diabetic nephropathy","volume":"35","author":"RG Larkins","year":"1992","journal-title":"Diabetologia"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/00004872-200205000-00034","article-title":"Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria","volume":"20","author":"JM Forbes","year":"2002","journal-title":"J Hypertens"},{"key":"ref43","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)."},{"key":"ref44","doi-asserted-by":"crossref","first-page":"E1016","DOI":"10.1152\/ajpendo.00515.2011","article-title":"Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney","volume":"302","author":"N Grobe","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"F82","DOI":"10.1152\/ajprenal.00139.2006","article-title":"Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II","volume":"292","author":"HA Shaltout","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"F1374","DOI":"10.1152\/ajprenal.00656.2011","article-title":"Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes","volume":"302","author":"LM Yamaleyeva","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1113\/expphysiol.2007.040352","article-title":"Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor","volume":"93","author":"RA Lew","year":"2008","journal-title":"Exp Physiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/HJH.0b013e32834f04b6","article-title":"Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications","volume":"30","author":"A Soro-Paavonen","year":"2012","journal-title":"J Hypertens"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1681\/ASN.2008070667","article-title":"Lowering blood pressure reduces renal events in type 2 diabetes","volume":"20","author":"BE de Galan","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MAJ.0b013e3181b90c25","article-title":"Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes","volume":"338","author":"T Saito","year":"2009","journal-title":"Am J Med Sci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1681\/ASN.2006060554","article-title":"Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease","volume":"18","author":"T Yamamoto","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/10641963.2011.649932","article-title":"Overexpression of urinary N-domain ACE in chronic kidney dysfunction in Wistar rats","volume":"34","author":"DY Arita","year":"2012","journal-title":"Clin Exp Hypertens"},{"key":"ref53","first-page":"581780","article-title":"N-domain isoform of Angiotensin I converting enzyme as a marker of hypertension: populational study","volume":"2012","author":"LC Maluf-Meiken","year":"2012","journal-title":"Int J Hypertens"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/EJE-12-0782","article-title":"High Urinary ACE2 Concentrations Are Associated with Severity of Glucose Intolerance and Microalbuminuria","volume":"168","author":"SE Park","year":"2013","journal-title":"Eur J Endocrinol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0062833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T07:42:41Z","timestamp":1563003761000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0062833"}},"subtitle":[],"editor":[{"given":"Michael","family":"Bader","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0062833","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,30]]}}}